To assess GM-CSF levels in the undifferentiated phases of human arthritis, we first determined GM-CSF expression in the ST sublining of persistent UA, UA>RA, UA>PsA, established RA and PsA patients, and healthy controls (Figures 1A, B). This evidence concerns the gene CSF2 and rheumatoid arthritis.